A Stanford psychiatrist is researching the effects of ketamine on the brains of patients with obsessive-compulsive disorder, hoping to determine why, in studies, the drug has provided relief from symptoms.
An antibody to the cell receptor PD-1 may launch a two-pronged assault on cancer by initiating attacks by both T cells and macrophages, a Stanford study has found.
Many areas across the globe have few autism experts, leading to delayed care for kids who live there. Stanford scientists have launched a crowdsourcing project to pinpoint such geographic gaps, and find ways to fill them.
More than doubling its current size, the expanded Lucile Packard Children’s Hospital Stanford will transform the patient experience through family-centered design and technological innovation, while setting new standards for sustainability in hospital design.
Collaboration between two Stanford labs has resulted in the discovery of a molecular cause for lymphedema and the first possible drug treatment for it.
The spring issue of the magazine highlights how sex and gender differences should be part of medical education, research and care. It includes a Q&A with Barbra Streisand on fighting gender discrimination in cardiovascular research and treatment.